Trial intelligence / Profile preview

Modafinil for the treatment of fatigue in lung cancer

2008-006486-88Phase 4Completed

Sponsor
University of Oxford
Start
Apr 2009
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, randomised, double-blind trial in cancer-related fatigue (CRF) and non-small cell lung cancer (NSCLC) comparing Modafinil with Placebo (2 arms). Started Apr 2009; status: completed.

02

Drugs

modafinil
03

Conditions

cancer-related fatigue (CRF)non-small cell lung cancer (NSCLC)

Beyond the preview

Go deeper on 2008-006486-88.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2008-006486-88.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call